THE BRITISH ONCOLOGY PHARMACY ASSOCIATION

Home - BOPA | British Oncology Pharmacy Association

Maximising the potential of the cancer Pharmacy team to optimise the care of people living with cancer BOPA is the British Oncology Pharmacy Association. It was founded in the autumn of 1996. BOPA promotes excellence in pharmaceutical care of British Cancer Patients
1065026
IČO
1997
Založeno
Surrey
Adresa
bopawebsite.org
Web
BOPACommittee
Twitter (3318)
BOPACommittee
Facebook (3617)
Popis

The British Oncology Pharmacy Association

Overview

The British Oncology Pharmacy Association (BOPA) is a registered charity in the United Kingdom, focused on promoting excellence in the pharmaceutical care of cancer patients. With a charity number of 1065026, BOPA is dedicated to advancing oncology pharmacy practice through education, research, and innovation.

Mission and Objectives

BOPA aims to enhance patient care and outcomes by supporting pharmacists specializing in oncology. The organization fosters a collaborative environment among healthcare professionals, ensuring that the latest advancements in oncology pharmacy are disseminated and implemented effectively.

Activities and Initiatives

BOPA engages in various activities, including providing e-learning modules, hosting forums, and offering support for credentialing pharmacists. A notable initiative is the BOPA Cancer Consultant Pharmacist Credentialing Support Series, which assists pharmacists in their professional development as consultant pharmacists.

Organizational Structure

The organization operates through an Executive Committee, which oversees the strategic direction of BOPA. The Executive Committee is supported by several subcommittees that focus on specific aspects of oncology pharmacy, ensuring the organization stays at the forefront of care advancements.

External Collaboration

BOPA also collaborates with affiliated groups to amplify its impact on cancer care. These partnerships enable BOPA to work jointly with other organizations to enhance education, communication, and innovation in the field of oncology pharmacy.

Engagement in Health Policy

BOPA actively participates in health policy discussions, such as providing submissions to the National Institute for Health and Care Excellence (NICE) on the appraisal of various cancer treatments. This involvement reflects the organization's commitment to influencing healthcare decisions that affect oncology pharmacy services.

[1] https://register-of-charities.charitycommission.gov.uk/en/charity-search/-/charity-details/3938389/contact-information [2] https://www.bopa.org.uk [3] https://register-of-charities.charitycommission.gov.uk/charity-details/?regid=1065026&subid=0 [4] https://www.bopa.org.uk/about/ [5] https://www.nice.org.uk/guidance/ta100/documents/british-oncology-pharmacy-association-12

Více

Novinky

Poslední komentáře

🌟 Excited to see the launch of the UTIC course! This is such an amazing opportunity for pharmacy professionals to deepen their understanding of targeted therapies and immunotherapies. Together, we can improve the care for those fighting cancer! 💪💙
detail
🗓️ Can't wait for the 28th BOPA Annual Conference in Belfast! It's a great chance to network, learn, and share knowledge with fellow professionals. Let’s all make the most out of this opportunity to advance our skills for the benefit of cancer patients! 🌍✨
detail

Poslední diskuze

What impact do you think the UTIC course will have on the practice and knowledge of pharmacy teams working with cancer patients?
Odpovědí: 3, Naposledy před 1 den detail
How can BOPA further engage with its members to enhance participation in the upcoming 28th Annual Conference and make it a more enriching experience?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
THE BRITISH ONCOLOGY PHARMACY ASSOCIATION logo
THE BRITISH ONCOLOGY PHARMACY ASSOCIATION
+ Sledovat
4.5
Reviews
Surrey
Místo
O společnosti

- E20, E50, H60 -

UTIC Course The UTIC course has been awarded a FIP Seal. The FIP Seal for programmes is awarded to professional development programmes and courses and provides a visible signal of the alignment of a provider of programmes with the FIP mission to advance pharmacy worldwide. BOPA and ISOPP have collaborated to create the Understanding targeted therapies and immunotherapies for cancer Course UTIC in 2024. UTIC youtick is a learning course over five modules incorporating twenty four 68 mins videos taking you on a journey of learning and discovery about targeted therapies and immunotherapies used for the treatment of cancer.

Nemocnice a zařízení primární zdravotní péče Rehabilitační zdravotnické služby Výzkum nemocí souvisejících s alergiemi
23 Vacancy More Detail